address1,city,state,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,irWebsite,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,allTimeHigh,allTimeLow,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,shortName,longName,corporateActions,postMarketTime,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,marketState,regularMarketChangePercent,regularMarketPrice,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,hasPrePostMarketData,firstTradeDateMilliseconds,postMarketChangePercent,postMarketPrice,postMarketChange,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,dividendDate,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,displayName,trailingPegRatio
126 East Lincoln Avenue,Rahway,NJ,07065,United States,908 740 4000,https://www.merck.com,Drug Manufacturers - General,drug-manufacturers-general,Drug Manufacturers - General,Healthcare,healthcare,Healthcare,"Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.",73000,"[{'maxAge': 1, 'name': 'Mr. Robert M. Davis J.D.', 'age': 58, 'title': 'Chairman, President & CEO', 'yearBorn': 1967, 'fiscalYear': 2024, 'totalPay': 4946636, 'exercisedValue': 12137946, 'unexercisedValue': 8920883}, {'maxAge': 1, 'name': 'Ms. Caroline A. Litchfield', 'age': 55, 'title': 'Executive VP & CFO', 'yearBorn': 1970, 'fiscalYear': 2024, 'totalPay': 2647054, 'exercisedValue': 2581579, 'unexercisedValue': 7022207}, {'maxAge': 1, 'name': 'Ms. Betty D. Larson', 'age': 49, 'title': 'Executive VP & Chief Human Resources Officer', 'yearBorn': 1976, 'fiscalYear': 2024, 'totalPay': 2294965, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Richard R. DeLuca Jr.', 'age': 62, 'title': 'Executive VP & President of Merck Animal Health', 'yearBorn': 1963, 'fiscalYear': 2024, 'totalPay': 2169938, 'exercisedValue': 0, 'unexercisedValue': 5823540}, {'maxAge': 1, 'name': 'Dr. Dean Y. Li M.D., Ph.D.', 'age': 61, 'title': 'Executive VP & President of Merck Research Laboratories', 'yearBorn': 1964, 'fiscalYear': 2024, 'totalPay': 3281100, 'exercisedValue': 932530, 'unexercisedValue': 4699987}, {'maxAge': 1, 'name': 'Mr. Dalton E. Smart III', 'age': 58, 'title': 'Senior VP of Finance, Principal Accounting Officer & Global Controller', 'yearBorn': 1967, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David Michael Williams', 'age': 55, 'title': 'Executive VP and Chief Information & Digital Officer', 'yearBorn': 1970, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Peter  Dannenbaum', 'title': 'Vice President of Investor Relations', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jennifer L. Zachary J.D.', 'age': 46, 'title': 'Executive VP & General Counsel', 'yearBorn': 1979, 'fiscalYear': 2024, 'totalPay': 2732334, 'exercisedValue': 3461623, 'unexercisedValue': 4142191}, {'maxAge': 1, 'name': 'Mr. Sanat  Chattopadhyay', 'age': 65, 'title': 'Executive VP & President of Merck Manufacturing Division', 'yearBorn': 1960, 'fiscalYear': 2024, 'totalPay': 2488990, 'exercisedValue': 12488854, 'unexercisedValue': 7539200}]",6,5,4,2,3,1767225600,1735603200,http://www.merck.com/investors/home.html,[],86400,2,110.99,110.87,110.22,112.4799,110.99,110.87,110.22,112.4799,3.4,3.08,1765756800,0.4286,3.05,0.298,14.62037,14.824263,9137817,9137817,13487198,11639800,11639800,0.0,0.0,600,300,276080001024,73.31,112.9,134.63,0.265055,4.2979684,98.4204,86.07485,3.2,0.028831428,USD,False,297554935808,0.29632,2478026480,2482022536,37162304,27626151,1763078400,1765756800,0.015,0.00058,0.801,2.34,0.0167,2497783212,20.845,5.3024707,1735603200,1767139200,1759190400,0.832,19033999360,7.56,7.45602,1048:1000,1622678400,4.632,9.439,0.09457314,0.19362879,0.85,1765756800,EQUITY,110.53,135.0,83.0,113.33333,115.0,1.89655,buy,27,18214000640,7.338,31523000320,41373999104,1.09,1.661,64234999808,79.708,25.559,0.13755,0.39485002,50007998464,14527875072,17064999936,0.87,0.037,0.77852,0.49074,0.40802,USD,MRK,en-US,US,Equity,Nasdaq Real Time Price,True,HIGH,"Merck & Company, Inc.","Merck & Co., Inc.",[],1768006694,1767992402,NYQ,finmb_288502,America/New_York,EST,-18000000,us_market,False,CLOSED,-0.414451,110.53,12.335483,12.109596,0.12303949,24.455147,0.2841149,15,0,1.9 - Buy,False,True,-252322200000,0.08613009,110.6252,0.095199585,-0.459999,110.22 - 112.4799,NYSE,13487198,37.22,0.50770706,73.31 - 112.9,-2.3700027,-0.020992052,9.457314,1767830400,1770125400,1770125400,1770125400,1770127200,1770127200,False,7.56,7.45602,8.96033,Merck &,1.1642
